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Abstract
A selection of plasmid-mediated AmpC-producing Escherichia coli
isolates carrying blaCMY-2 from Swedish broilers were characterized
to establish their relatedness to and a possible overlap with human
clinical E. coli isolates. The results showed diversity among the
E. coli isolated from broilers, indicating that the spread in the
population was not due to one strain. However, only one type of
plasmid belonging to replicon type incK was identified. Further-
more, there were no indications of spread of blaCMY-2 E. coli isolates
from broilers to human clinical settings, although Swedish broilers
may be a source of blaCMY-2 and/or the plasmid carrying blaCMY-2.
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The increasing trend worldwide of Enterobacteriaceae produc-
ing extended-spectrum beta-lactamases (ESBL) and plasmid-
mediated AmpC (pAmpC) in clinical settings is of great
concern, due to their ability to hydrolyse third-generation
cephalosporins. Food-producing animals, poultry in particular,
have been suggested to be a potential reservoir for these types
of bacteria and the genes encoding ESBL/pAmpC. In a recent
report the European Food Safety Authority concluded that
there is indirect evidence that transmission of ESBL- and
pAmpC-producing Enterobacteriaceae and genes encoding ESBL
and pAmpC can occur between food-producing animals,
especially broilers, and humans [1]. In Sweden, prescription
of antimicrobials to animals is very limited compared with that
in other European countries [2]. It was therefore an
unexpected finding in 2010 that 34% of broilers in Sweden
carried ESBL- or pAmpC-producing E. coli [3]. The only genes
identified were blaCTX-M-1 and blaCMY-2, with blaCMY-2 clearly
dominating. The cause of the high occurrence in broilers is not
clear, but there are indications that imported breeding stocks
may play a central role [3]. Furthermore, it is uncertain
whether the high occurrence of blaCMY-2 has influenced the
incidence among humans in clinical settings in Sweden. In this
study we characterized a selection of blaCMY-2 E. coli isolated
from the intestinal content of Swedish broilers and investi-
gated the possibility of an overlap with human clinical blaCMY-2
E. coli isolates.
Twenty-two E. coli isolates carrying blaCMY-2 from broilers
were obtained from the monitoring program SVARM 2010 [3]
and were characterized using pulsed-field gel electrophoresis
(PFGE) [4], multilocus sequence typing (MLST) (http://mlst.ucc.
ie/) and plasmid replicon (PR) typing [5]. Antimicrobial suscep-
tibility was assessed using the VetMIC GN-mo plates (SVA,
Uppsala, Sweden) interpreted with EUCAST epidemiological
cut-off values. Transferability of blaCMY-2 was tested through
conjugation to E. coli HMS174. Transformation was performed
on isolates unable to transfer blaCMY-2 through conjugation and
transconjugants carrying multiple PR-types. Plasmid DNA was
transformed using ElectroMaxTMDH10BTM. Transconjugants/
transformants were tested for antimicrobial susceptibility,
presence of AmpC genes [6] and PR types. The size of
transferred plasmids was determined by nuclease-S1 treatment
and PFGE according to Barton [7]. The 22 isolates belonged to
11 STs (Fig. 1; Table 1). Two isolates were defined as multi-
resistant (resistant to  three classes) and 10 were resistant to
beta-lactams only. There was an association between ST and
resistance pattern (Fig. 1; Table 1). Isolates belonging to the
same ST generally showed identical or closely related PFGE
patterns (Fig. 1). Six of the isolates were non-typeable by PFGE
(Table 1). The blaCMY-2 was identified on an IncK plasmid,
except for one isolate where the blaCMY-2 could not be
transferred. The blaCMY-2 + IncK plasmids transferred no
additional resistance phenotype and were 60–100 kb in size.
Compared with data from other European countries [1], the
Swedish isolates showed a more homogeneous population
structure regarding both phenotype and genotype. The sampling
was designed so that each isolate represented a unique slaughter
batch. Furthermore, the Swedish broiler houses are cleaned and
disinfected between batches. Therefore sampling bias is not the
likely explanation for these results. Furthermore, the high
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prevalence in Sweden cannot be explained by antibiotic usage
because this is very limited and no cephalosporins were
prescribed [8]. A potential explanation could be transmission
of cephalosporin-resistant E. coli through the production
pyramid. This type of transmission has been suggested in earlier
studies, which have described the occurrence of cephalosporin-
resistant E. coli, mainly pAmpC producing, in the production
pyramid [1,8,9]. However, other sources, such as feed, the
environment and recirculation, may play a role, but this need to
be further studied.
To investigate the potential influence of broiler isolates in
human clinical settings, 72 isolates carrying blaCMY-2 collected at
the Swedish Institute for Communicable Disease Control (SMI)
from clinical laboratories selected tomirror the sampling period
for the broilers and six isolates from a 2009 point prevalence
study were characterized [10] (Edquist P, Olsson Liljequst B,
Tegmark Wisell K, Giske CG, Unpublished data ). Twenty-one
of the isolates tested positive for the IncK plasmid and these
were subjected to PFGE, with four found to be non-typeable
(Table 1). None of the 17 typeable isolates clustered with
broiler isolates (Fig. 1). Moreover, the human isolates had a
higher heterogeneity than the broiler isolates, were generally
resistant to a wider range of antimicrobials and carried more PR
types. Through transformation, 20 isolates transferred blaCMY-2,
19 tested positive for IncK andone for IncI1.Noother resistance
Isolate ID Plasmid replicon types Non-beta-lactam
Resistance pattern
MLST
87.5
64.7
72.2
59.9
57.5
85.1
95.5
90.7
71.6
66.4
95.0
61.5
97.7
87.2
77.2
60.4
56.9
79.1
60.8
56.7
53.4
70.3
53.0
46.7
64.3
80.0
52.8
46.3
50.0
10
0
908070605040
H70 N.D. K, FIB, FII CiTc
H30 N.D. K, FIB, FII KmTc
H27 N.D. K, FIB, FII, N
H44 N.D. K, FIB, FII, I1 CiNaSuTm
H97 N.D. K, FIB, FII CiNa
C20 ST69 K, FIB, FII KmSmSuTc
H20 N.D. K, FIB, FII CiNal
C55 ST115 K, FIB, F
C23 ST10 K, FIB
C68 ST68 K, FIB, F CiNa
C05 ST68 K, FIB, F CiNa
C78 ST68 K, FIB, F CiNa
C97 ST68 K, FIB, F CiNa
C82 ST770 K, FIB, F
C27 ST770 K, FIB, F
C38 ST2167 K, FIB, P Su
C79 ST2167 K, FIB, P Su
C84 ST2167 K, FIB, P Su
C19 ST2167 K, FIB, P Su
C98 ST57 K, FIB, F Su
C75 ST10 K, FIB
C63 ST10 K, FIB
H52 N.D. K, I1
H07 N.D. K, FIB, FII, N CiNa
H77 N.D. K, FIB, FII
H66 N.D. K, FIA, FIB, FII, Y CiNaGmSmSu
H33 N.D. K, FIB, FII, X CCiNaFf
H08 N.D. K, FIB, X
H14 N.D. K, FIB, FII, N, X CiTc
H80 N.D. K, FIA, FIB, FII, I, Y CCiNaGmKmSmSuTmTc
H17 N.D. K, FIB, FII, Y, N CiNaSmSuTmTc
H22 N.D. K, FIB, FII, HI2 CCiNaFf
H32 N.D. K, FIB, FII SmSuTm
FIG. 1. Dendogram showing the genotypic relatedness of 16 Escherichia coli carrying blaCMY-2 isolates of broiler origin (C) and 17 E. coli carrying
blaCMY-2 isolates of human patient origin (H) based on pulsed-field gel electrophoresis. For comparison, Dice coefficient and unweighted pair group
method with arithmetic mean cluster analysis was performed, with position tolerance and optimization both set at 1%. The scale bar represents
percentage similarity and the vertical dotted line indicates  80% similarity. Multilocus sequencing type (MLST) was not determined (ND) for isolates
of human origin. Chloramphenicol (C), ciprofloxacin (Ci), nalidixic acid (Na), colistin (Cs), florfenicol (Ff), gentamicin (Gm), kanamycin (Km),
streptomycin (Sm), sulphamethoxazole (Su), trimethoprim (Tm) and tetracycline (Tc).
TABLE 1. Characterization of pulsed-field gel electrophore-
sis non-typeable human clinical (H) and broiler (C) E. coli
isolates carrying blaCMY-2
Isolate ID
MLST
(clonal complex)
Plasmid
replicon types
Non-beta-lactam
resistance pattern
C30 ST117 (N.D.) FIA, FIB CiNa
C33 ST57 (CC350) K, FIB, F, I1
C41 ST2183 (N.D.) K, Y CiNaTc
C53 ST10 (CC10) K
C54 ST2184 (N.D.) K
C65 ST57 (CC350) K, FIB, F, I1
H00 N.D. K, FIB,FII CCiNaSmSuTmTc
H13 N.D. K, FIA, FIB, N CCiNaSmSuTc
H33 N.D. K, FIA, FIB CiNaGmSmSuTmtc
H47 N.D. K
C, Chloramphenicol; Ci, Ciprofloxacin; Na, Nalidixic acid; Gm, Gentamicin; Sm,
Streptomycin; Su, Sulphamethoxazole; Tm, Trimethoprim; Tc, Tetracycline; ND,
not determined; MLST, multilocus sequence typing.
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phenotypes were transferred and the plasmids were in the same
size-range as those from broilers, with one exception, a 200 kb
plasmid. The study by Leverstein-van Hall et al. [11] clearly
demonstrated a relationship between ESBL-producing isolates
of broiler and human origin. In contrast, the Swedish human and
broiler isolates with blaCMY-2 appeared very distinct both
genotypically and phenotypically (Fig. 1), at least among the
limited number investigated here. These results indicate that
there has been very limited or no direct transmission of E. coli
isolates in Sweden between broilers and humans. In addition, a
point prevalence study that involved the majority of Swedish
human clinical laboratories, performed in Sweden in 2009 by
SMI, found that a minority (approximately 6%) of cephalosporin-
resistant E. coli carried pAmpC (Edquist P, Olsson Liljequst B,
Tegmark Wisell K, Giske CG, Unpublished data).
Despite the differences in isolate level, it is possible that
transmission of the plasmid has occurred. In earlier studies on
human clinical isolates, blaCMY-2 has mainly been described on
other RTs [12], although there is a recent example of
dissemination of IncK-blaCMY-2 among E. coli isolates in intensive
care units in Canada [13]. The prevalence of IncK-blaCMY-2
plasmids in Europe appears also to have increased in the broiler
population over the last few years [14], which in the future may
influence occurrence among humans. Overall, the potential
transfer appears very limited in Sweden, as the E. coli isolates
with IncK-blaCMY-2 constituted a clear minority of the human
clinical isolates, whereas the combination is almost universal in
isolates from broilers. A limitation of this study was the small
number of isolates included and the lack of temporal or spatial
linkages to the human isolates. However, it is unlikely that the
combination of genes in the broiler population has changed
markedly over time. In addition, continued surveillance has also
shown that blaCMY-2 continues to dominate [8].
No closely related human and broiler E. coli isolates were
identified, indicating limited transmission of isolates between the
two populations. However, because IncK-plasmids were iden-
tified in both populations, transmission of the plasmid cannot be
ruled out. The high occurrence of pAmpC-producing E. coli in
Swedish broilers is in any case distressing. Because Sweden is a
low-prevalence country as regards ESBL and pAmpC, the
occurrence in broilers may have a higher impact in the future.
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